Mirum Pharmaceuticals (MIRM) PT Raised to $130 at Stifel

April 28, 2026 5:05 PM

Stifel analyst James Condulis raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $130.00 (from $125.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found